| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
101
|
A revised definition for cure of childhood acute lymphoblastic leukemia.
|
Leukemia
|
2014
|
0.95
|
|
102
|
HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies.
|
Blood
|
2014
|
0.94
|
|
103
|
NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity.
|
Nat Genet
|
2016
|
0.93
|
|
104
|
Shared acquired genomic changes in zebrafish and human T-ALL.
|
Oncogene
|
2011
|
0.93
|
|
105
|
Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia.
|
Cancer Cell
|
2016
|
0.93
|
|
106
|
Evidence for age as a modifier of genetic associations for lipid levels.
|
Ann Hum Genet
|
2011
|
0.92
|
|
107
|
Integrated analysis of pharmacologic, clinical and SNP microarray data using Projection Onto the Most Interesting Statistical Evidence with Adaptive Permutation Testing.
|
Int J Data Min Bioinform
|
2011
|
0.91
|
|
108
|
Calcium and cholecalciferol supplementation provides no added benefit to nutritional counseling to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia (ALL).
|
Pediatr Blood Cancer
|
2014
|
0.90
|
|
109
|
Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children.
|
Nat Commun
|
2015
|
0.89
|
|
110
|
Germline ETV6 Mutations Confer Susceptibility to Acute Lymphoblastic Leukemia and Thrombocytopenia.
|
PLoS Genet
|
2015
|
0.87
|
|
111
|
Genome-wide analysis links NFATC2 with asparaginase hypersensitivity.
|
Blood
|
2015
|
0.87
|
|
112
|
Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia.
|
Eur J Cancer
|
2014
|
0.87
|
|
113
|
Utility of automated counting to determine absolute neutrophil counts and absolute phagocyte counts for pediatric cancer treatment protocols.
|
Cancer
|
2004
|
0.86
|
|
114
|
Late-onset delayed excretion of methotrexate.
|
Cancer Chemother Pharmacol
|
2004
|
0.86
|
|
115
|
Epigenetic regulation of human gamma-glutamyl hydrolase activity in acute lymphoblastic leukemia cells.
|
Am J Hum Genet
|
2006
|
0.85
|
|
116
|
Deregulation of DUX4 and ERG in acute lymphoblastic leukemia.
|
Nat Genet
|
2016
|
0.84
|
|
117
|
Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia.
|
Cancer
|
2014
|
0.84
|
|
118
|
Clinical consequences of hyperglycemia during remission induction therapy for pediatric acute lymphoblastic leukemia.
|
Leukemia
|
2008
|
0.84
|
|
119
|
Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic Trait.
|
Clin Pharmacol Ther
|
2016
|
0.82
|
|
120
|
The controversy of varicella vaccination in children with acute lymphoblastic leukemia.
|
Pediatr Blood Cancer
|
2010
|
0.82
|
|
121
|
Influence of Cranial Radiotherapy on Outcome in Children With Acute Lymphoblastic Leukemia Treated With Contemporary Therapy.
|
J Clin Oncol
|
2016
|
0.82
|
|
122
|
Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments.
|
Cancer Chemother Pharmacol
|
2013
|
0.82
|
|
123
|
Prognostic impact of absolute lymphocyte counts at the end of remission induction in childhood acute lymphoblastic leukemia.
|
Cancer
|
2013
|
0.82
|
|
124
|
Skeletal, neuromuscular and fitness impairments among children with newly diagnosed acute lymphoblastic leukemia.
|
Leuk Lymphoma
|
2014
|
0.81
|
|
125
|
Genetic predictors of glucocorticoid-induced hypertension in children with acute lymphoblastic leukemia.
|
Pharmacogenet Genomics
|
2008
|
0.81
|
|
126
|
Neuropathic pain during treatment for childhood acute lymphoblastic leukemia.
|
Pediatr Blood Cancer
|
2011
|
0.81
|
|
127
|
Concordant gene expression in leukemia cells and normal leukocytes is associated with germline cis-SNPs.
|
PLoS One
|
2008
|
0.80
|
|
128
|
Outcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levels.
|
Blood
|
2015
|
0.80
|
|
129
|
Conservative management of pancreatic pseudocysts in children with acute lymphoblastic leukemia.
|
J Pediatr Hematol Oncol
|
2009
|
0.80
|
|
130
|
Prospective randomized crossover evaluation of three anesthetic regimens for painful procedures in children with cancer.
|
J Pediatr
|
2012
|
0.80
|
|
131
|
Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol.
|
J Clin Oncol
|
2016
|
0.80
|
|
132
|
Neurologic morbidity and quality of life in survivors of childhood acute lymphoblastic leukemia: a prospective cross-sectional study.
|
J Cancer Surviv
|
2014
|
0.80
|
|
133
|
Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids.
|
J Clin Oncol
|
2015
|
0.79
|
|
134
|
Effect of premedications in a murine model of asparaginase hypersensitivity.
|
J Pharmacol Exp Ther
|
2015
|
0.79
|
|
135
|
Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia.
|
J Clin Oncol
|
2016
|
0.79
|
|
136
|
SVSI: fast and powerful set-valued system identification approach to identifying rare variants in sequencing studies for ordered categorical traits.
|
Ann Hum Genet
|
2015
|
0.78
|
|
137
|
Modifiable Factors Associated With Aging Phenotypes Among Adult Survivors of Childhood Acute Lymphoblastic Leukemia.
|
J Clin Oncol
|
2016
|
0.78
|
|
138
|
NK cell genotype and phenotype at diagnosis of acute lymphoblastic leukemia correlate with postinduction residual disease.
|
Clin Cancer Res
|
2014
|
0.77
|
|
139
|
Prophylactic Trimethoprim-Sulfamethoxazole Does Not Affect Pharmacokinetics or Pharmacodynamics of Methotrexate.
|
J Pediatr Hematol Oncol
|
2016
|
0.76
|
|
140
|
Genome-wide single-nucleotide polymorphism analysis revealed SUFU suppression of acute graft-versus-host disease through downregulation of HLA-DR expression in recipient dendritic cells.
|
Sci Rep
|
2015
|
0.76
|
|
141
|
Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia.
|
Blood
|
2015
|
0.76
|
|
142
|
Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapy.
|
Leukemia
|
2016
|
0.76
|
|
143
|
Promoter polymorphisms in the β-2 adrenergic receptor are associated with drug-induced gene expression changes and response in acute lymphoblastic leukemia.
|
Clin Pharmacol Ther
|
2010
|
0.76
|
|
144
|
Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic Leukemia.
|
PLoS One
|
2015
|
0.76
|
|
145
|
A variant at 9p21.3 functionally implicates CDKN2B in paediatric B-cell precursor acute lymphoblastic leukaemia aetiology.
|
Nat Commun
|
2016
|
0.76
|
|
146
|
MicroRNAs Form Triplexes with Double Stranded DNA at Sequence-Specific Binding Sites; a Eukaryotic Mechanism via which microRNAs Could Directly Alter Gene Expression.
|
PLoS Comput Biol
|
2016
|
0.76
|
|
147
|
Clinical impact of sedentary behaviors in adult survivors of acute lymphoblastic leukemia: A report from the St. Jude Lifetime Cohort study.
|
Cancer
|
2017
|
0.75
|
|
148
|
Successful treatment of pediatric plasmacytoid dendritic cell tumors with a contemporary regimen for acute lymphoblastic leukemia.
|
Pediatr Blood Cancer
|
2013
|
0.75
|
|
149
|
Bone turnover in long-term survivors of childhood acute lymphoblastic leukemia.
|
Pediatr Blood Cancer
|
2014
|
0.75
|
|
150
|
Headache types, related morbidity, and quality of life in survivors of childhood acute lymphoblastic leukemia: a prospective cross sectional study.
|
Eur J Paediatr Neurol
|
2014
|
0.75
|
|
151
|
Emotional distress in parents of long-term survivors of childhood acute lymphoblastic leukemia.
|
Psychooncology
|
2014
|
0.75
|
|
152
|
Effect of allopurinol versus urate oxidase on methotrexate pharmacokinetics in children with newly diagnosed acute lymphoblastic leukemia.
|
Cancer
|
2010
|
0.75
|
|
153
|
Dietary Protein Intake and Lean Muscle Mass in Survivors of Childhood Acute Lymphoblastic Leukemia: Report From the St. Jude Lifetime Cohort Study.
|
Phys Ther
|
2016
|
0.75
|
|
154
|
A genetic factor associated with low final bone mineral density in children after a long-term glucocorticoids treatment.
|
Pharmacogenomics J
|
2016
|
0.75
|
|
155
|
Cognitive, behaviour, and academic functioning in adolescent and young adult survivors of childhood acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study.
|
Lancet Psychiatry
|
2016
|
0.75
|
|
156
|
Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
|
Lancet Haematol
|
2016
|
0.75
|
|
157
|
Whole transcriptome sequencing identified a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP.
|
Genome Res
|
2016
|
0.75
|
|
158
|
Association between dehydroepiandrosterone-sulfate and attention in long-term survivors of childhood acute lymphoblastic leukemia treated with only chemotherapy.
|
Psychoneuroendocrinology
|
2016
|
0.75
|
|
159
|
Infection-related complications during treatment for childhood acute lymphoblastic leukemia.
|
Ann Oncol
|
2017
|
0.75
|
|
160
|
The effect of body mass index at diagnosis on clinical outcome in children with newly diagnosed acute lymphoblastic leukemia.
|
Blood Cancer J
|
2017
|
0.75
|
|
161
|
Osteonecrosis is unrelated to hip anatomy in children with acute lymphoblastic leukemia.
|
Pediatr Blood Cancer
|
2016
|
0.75
|
|
162
|
Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy.
|
Clin Pharmacol Ther
|
2017
|
0.75
|
|
163
|
Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemia.
|
Leukemia
|
2017
|
0.75
|
|
164
|
Neurocognitive outcomes among children who experienced seizures during treatment for acute lymphoblastic leukemia.
|
Pediatr Blood Cancer
|
2017
|
0.75
|
|
165
|
Impact of sleep, fatigue, and systemic inflammation on neurocognitive and behavioral outcomes in long-term survivors of childhood acute lymphoblastic leukemia.
|
Cancer
|
2017
|
0.75
|
|
166
|
Whole-genome non-coding sequence analysis in T-cell acute lymphoblastic leukemia identifies oncogene enhancer mutations.
|
Blood
|
2017
|
0.75
|
|
167
|
Palmar-plantar erythrodysesthesia syndrome following treatment with high-dose methotrexate or high-dose cytarabine.
|
Cancer
|
2017
|
0.75
|
|
168
|
Genetics of pleiotropic effects of dexamethasone.
|
Pharmacogenet Genomics
|
2017
|
0.75
|
|
169
|
Novel variants in NUDT15 and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestry.
|
Blood
|
2017
|
0.75
|
|
170
|
Effect of cranial irradiation on sperm concentration of adult survivors of childhood acute lymphoblastic leukemia: a report from the St. Jude Lifetime Cohort Study†.
|
Hum Reprod
|
2017
|
0.75
|
|
171
|
Premature Ovarian Insufficiency in Childhood Cancer Survivors: A Report from the St. Jude Lifetime Cohort.
|
J Clin Endocrinol Metab
|
2017
|
0.75
|
|
172
|
A p53-regulated apoptotic gene signature predicts treatment response and outcome in pediatric acute lymphoblastic leukemia.
|
Cancer Manag Res
|
2017
|
0.75
|
|
173
|
Levofloxacin Prophylaxis During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia.
|
Clin Infect Dis
|
2017
|
0.75
|